84 related articles for article (PubMed ID: 17004266)
1. The influence of CTLA-4 gene polymorphisms on liver transplant outcomes.
Perkins JD
Liver Transpl; 2006 Oct; 12(10):1552-3. PubMed ID: 17004266
[No Abstract] [Full Text] [Related]
2. Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation.
Tapirdamaz O; Pravica V; Metselaar HJ; Hansen B; Moons L; van Meurs JB; Hutchinson IV; Shaw J; Agarwal K; Adams DH; Day CP; Kwekkeboom J
Gut; 2006 Jun; 55(6):863-8. PubMed ID: 16299026
[TBL] [Abstract][Full Text] [Related]
3. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study.
Gendzekhadze K; Rivas-Vetencourt P; Montano RF
Transpl Immunol; 2006 Nov; 16(3-4):194-9. PubMed ID: 17138053
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 CT60 A/G gene polymorphism in liver transplant recipients.
Azarpira N; Malekhosseini SA; Aghdaie MH; Daraie M
Exp Clin Transplant; 2010 Sep; 8(3):210-3. PubMed ID: 20716038
[TBL] [Abstract][Full Text] [Related]
5. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
6. Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation.
Vannucchi AM; Guidi S; Guglielmelli P; Glinz S; Lombardini L; Busca A; Locatelli F; Dall'Omo AM; Bosi A
Bone Marrow Transplant; 2007 Nov; 40(10):1001-2. PubMed ID: 17846597
[No Abstract] [Full Text] [Related]
7. Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant.
Wiśniewski A; Kusztal M; Magott-Procelewska M; Klinger M; Jasek M; Łuszczek W; Nowak I; Kosmaczewska A; Ciszak L; Frydecka I; Górski A; Kuśnierczyk P
Transplant Proc; 2006; 38(1):56-8. PubMed ID: 16504663
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in psoriasis vulgaris.
Luszczek W; Kubicka W; Jasek M; Baran E; Cisło M; Nockowski P; Luczywo-Rudy M; Wiśniewski A; Nowak I; Kuśnierczyk P
Int J Immunogenet; 2006 Jun; 33(3):217-24. PubMed ID: 16712655
[TBL] [Abstract][Full Text] [Related]
9. CT60 A/G marker of the 3'-UTR of the CTLA4 gene and liver transplant.
Muro M; Rojas G; Botella C; Miras M; Campillo JA; Minguela A; Sánchez-Bueno F; Bermejo J; Ramírez P; Alvarez-López MR
Transpl Immunol; 2008 Jan; 18(3):246-9. PubMed ID: 18047932
[TBL] [Abstract][Full Text] [Related]
10. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients.
Bandur S; Petrasek J; Hribova P; Novotna E; Brabcova I; Viklicky O
Transplantation; 2008 Nov; 86(9):1206-13. PubMed ID: 19005401
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
12. Possible association of CTLA-4 gene polymorphism with cyclosporine-induced gingival overgrowth in kidney transplant recipients.
Kusztal M; Radwan-Oczko M; Kościelska-Kasprzak K; Boratyńska M; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2763-5. PubMed ID: 18021981
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte-associated antigen-4 gene polymorphisms confer susceptibility to atopic asthma in Korean children.
Sohn MH; Kim SH; Song TW; Kim KW; Kim ES; Park HS; Kim KE
Pediatr Pulmonol; 2007 Jun; 42(6):542-7. PubMed ID: 17469155
[TBL] [Abstract][Full Text] [Related]
14. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
[TBL] [Abstract][Full Text] [Related]
15. Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background.
Bittencourt PL; Farias AQ; Porta G; Cançado EL; Miura I; Pugliese R; Kalil J; Goldberg AC; Carrilho FJ
J Clin Gastroenterol; 2008 Mar; 42(3):300-5. PubMed ID: 18223493
[TBL] [Abstract][Full Text] [Related]
16. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis.
Bagos PG; Karnaouri AC; Nikolopoulos GK; Hamodrakas SJ
Mult Scler; 2007 Mar; 13(2):156-68. PubMed ID: 17439880
[TBL] [Abstract][Full Text] [Related]
17. The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation.
Marder BA; Schröppel B; Lin M; Schiano T; Parekh R; Tomer Y; Murphy B
Am J Transplant; 2003 Apr; 3(4):424-31. PubMed ID: 12694064
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease.
Dallos T; Avbelj M; Barák L; Zapletalová J; Pribilincová Z; Krajcírová M; Kostálová L; Battelino T; Kovács L
Neuro Endocrinol Lett; 2008 Jun; 29(3):334-40. PubMed ID: 18580850
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.
Pavlova A; Diaz-Lacava A; Zeitler H; Satoguina J; Niemann B; Krause M; Scharrer I; Hoerauf A; Wienker T; Oldenburg J
Haemophilia; 2008 Mar; 14(2):355-60. PubMed ID: 18081831
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women.
Su TH; Chang TY; Lee YJ; Chen CK; Liu HF; Chu CC; Lin M; Wang PT; Huang WC; Chen TC; Yang YC
Carcinogenesis; 2007 Jun; 28(6):1237-40. PubMed ID: 17341658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
